Found: 7
Select item for more details and to access through your institution.
Discrimination of Cancer Stem Cell Markers ALDH1A1, BCL11B, BMI-1, and CD44 in Different Tissues of HNSCC Patients.
- Published in:
- Current Oncology, 2021, v. 28, n. 4, p. 2763, doi. 10.3390/curroncol28040241
- By:
- Publication type:
- Article
EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers.
- Published in:
- PLoS Biology, 2018, v. 16, n. 9, p. 1, doi. 10.1371/journal.pbio.2006624
- By:
- Publication type:
- Article
A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01646-1
- By:
- Publication type:
- Article
5ʹ-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells.
- Published in:
- Journal of Biomedical Science, 2023, v. 30, n. 1, p. 1, doi. 10.1186/s12929-023-00968-6
- By:
- Publication type:
- Article
SLUG‐related partial epithelial‐to‐mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 2, p. 347, doi. 10.1002/1878-0261.13075
- By:
- Publication type:
- Article
Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 4, p. 1040, doi. 10.1002/1878-0261.12886
- By:
- Publication type:
- Article
High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-32178-8
- By:
- Publication type:
- Article